Lymphomas - Refresher 2022

This course helps inform viewers about the multidisciplinary care of patients with lymphoma, the use of contemporary treatment fields (e.g. INRT, ISRT), appropriate use of technology (i.e. IMRT, VMAT, deep inspiration breath hold, proton beam therapy), new targeted therapies, immunotherapy, and treatment guidelines. The goal is to provide participants with updates on current clinical and translational initiatives in hematologic malignancies that are relevant to daily clinical practice. Additionally, participants will be updated on the appropriate integration of these advancements in their daily practice, including indication, patient selection, and combinations of different therapeutic modalities, and management of common toxicities.

This activity is available from May 30, 2022, through 11:59 p.m. Eastern time on May 29, 2025.

This activity was originally recorded at ASTRO’s virtual 2022 ASTRO Annual Refresher Course, March 27-27, 2022.

Target Audience

The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.

Learning Objectives

    Upon completion of this activity, participants should be able to do the following:

    • Discuss the current guideline-based clinical practice in hematologic malignancies.
    • Discuss PET/CT response adaptive radiotherapy protocols for Hodgkin lymphoma and non-Hodgkin lymphoma.
    • Explain the application of involved-site radiotherapy (ISRT) for all disease sites – including Hodgkin lymphoma, and non-Hodgkin lymphoma.
    • Discuss the importance of multidisciplinary care in hematologic malignancies and how to best apply it for optimal outcomes.
    • Describe key advances in immunotherapy and targeted therapy in hematologic malignancies.
    • Discuss recent advances in new technology integration (i.e. IMRT, VMAT, deep inspiration breath hold, proton therapy) and how and when to integrate them.
    • Discuss late effect of radiotherapy and how to best utilize current knowledge for decision-making.
    Course summary
    Available credit: 
    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Course opens: 
    05/30/2022
    Course expires: 
    05/29/2025
    Cost:
    $105.00
    Rating: 
    0

    Bradford Hoppe, MD, MPH is employed by Mayo Clinic and has no financial relationships with a commercial interest.

    The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.

    All relevant financial relationships have been mitigated.

    Disclosure link: 
    ASTRO Education Committee

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Price

    Cost:
    $105.00
    Please login or register to take this course.

    Course Fees:
    ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

    • Nonmember: $105
    • Member: $55

    If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

    Policies:

    No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

    Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

    The activity and its materials will only be available on the ASTRO website until May 29, 2025, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.